Original Research
Published on 13 Oct 2025
Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a prospective cohort study
in Cancer Immunity and Immunotherapy
- 251 views